Indefinite Delivery Contract 36C24822D0086

Award Date 8/22/22
Last Date to Order 7/31/27
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA), Veterans Health Administration, Network Contracting Office 17, has awarded a firm-fixed-price Indefinite Delivery Contract (IDC) to Karius, Inc., a life sciences company specializing in diagnostic services for infectious diseases. The IDC, valued at $600,000 and effective through July 31, 2027, allows the VA to purchase next-generation sequencing (NGS) tests from Karius at $2,000 per test. Karius has been identified as the sole responsible source...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $16 million single-award indefinite delivery contract (IDC) to Clear Labs Inc., a for-profit manufacturer and genomic analysis company, to provide COVID-19 genomic sequencing services and associated products. The contract, awarded in October 2022, has a period of performance through September 2027, with potential extensions. Under this IDC, Clear Labs has received multiple firm-fixed-price delivery orders to deliver...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a single-award indefinite delivery contract (IDC) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $3.4 million, 5-year IDC is for the provision of Cepheid test kits compatible with the VA's existing GeneXpert analyzers, including tests for COVID-19, influenza, and respiratory syncytial virus. The contract has no set-aside designation. Under the initial $579,360 firm fixed-price...
The Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) worth up to $147,080 to Natera Inc. to provide next generation sequencing and peripheral blood circulating tumor DNA (ctDNA) testing services in support of a VA-funded research study. The contract has a single award, no set-aside, and a period of performance from March 2025 to March 2028. The initial delivery order under this IDC is for $496,460 to fund research and development activities related to minimal...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA), Network Contracting Office (NCO) 21, to Diacarta, Inc. for reference laboratory testing services to aid in the diagnosis of VEXAS Syndrome. The contract has a total ceiling value of $200,000 and a period of performance from October 1, 2024 to September 30, 2029. The key services under this contract include specimen pickup, testing for somatic mutations of the UBA1 gene, reporting, and consultation....
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Biomerieux Inc. for VISN 8 Molecular Pathogen Detection. The contract, valued at $31,825,821.12, has an ultimate completion date of January 12, 2030, and was awarded on January 13, 2025. Under this IDC, Biomerieux Inc., through its Biomerieux, Inc. Division, will provide in-vitro diagnostic test panels, equipment, and related services to support molecular pathogen detection capabilities at...
The Department of Veterans Affairs (VA) has awarded Cepheid, a for-profit manufacturer of molecular diagnostic solutions, an Indefinite Delivery Contract (IDC) to provide reagents, test kits, and associated maintenance and support services to support the VA's clinical testing programs serving veterans. The contract, valued at up to $532,310.79, is a single-award IDC with the VA's Veterans Integrated Service Network 16 and does not have any set-aside designations. Under this IDC, the VA has...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA - VHA) awarded Cepheid a single award Indefinite Delivery Contract valued at up to $5,000,000 to provide molecular testing services. The contract utilizes an indefinite delivery/indefinite quantity structure with a period of performance through September 2028. Under the contract, Cepheid was issued a Firm Fixed Price delivery order valued at $786,443.51 to supply molecular testing from...
The Department of Veterans Affairs (VA), Veterans Health Administration (VHA), Veterans Integrated Service Network 2 (VISN 2) awarded Cepheid, a for-profit manufacturer of molecular diagnostic solutions, a $518,924.36 firm fixed price Blanket Purchase Agreement (BPA) call contract to provide Cepheid's diagnostic testing products. The one-year contract, starting on September 11, 2023 and ending on September 10, 2024, will enable VISN 2 to continuously procure Cepheid's molecular diagnostic...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a single award Indefinite Delivery Contract to Biomerieux Inc. with a potential value of $7.4 million to provide identification, antimicrobial susceptibility testing, and matrix-assisted laser desorption/ionization clinical proteomics technology solutions. The original solicitation posted on January 18, 2023 sought these laboratory diagnostic testing equipment and services with a...
  • 36C24822D0086
    Indefinite Delivery Contract
  • 3
    Federal Contract Awards

The Department of Veterans Affairs Veterans Health Administration (VHA) awarded a single-award indefinite delivery contract (IDC) to Karius, Inc., a life sciences company specializing in diagnostic testing, to provide next-generation sequencing tests at $2,000 per test. The $600,000 IDC, with an ultimate completion date of July 31, 2027, was awarded on August 22, 2022 to Karius as the sole responsible source capable of meeting the VHA's requirements.

Two task orders have been issued against this IDC so far. The first is a $120,000 firm-fixed price delivery order for Karius to perform next-generation sequencing tests at its Redwood City, California facilities from August 2023 to July 2024. The second is a $22,000 firm-fixed price delivery order for Karius to provide laboratory testing services for the Orlando VA Medical Center from August 2022 to July 2023, also to be performed in Redwood City. These contract actions support the VHA's efforts to provide quality healthcare and medical testing services to enrolled veterans across the United States.

Generated 7/23/24, 10:34 AM